Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Run‑Qiang Yuan"'
Autor:
Ya‑Qiang Huang, Hong‑Xing Huang, Xiao‑Hui Ling, Wei-de Zhong, Run‑Qiang Yuan, Sheng‑Bang Yang, Shao‑Peng Qiu, Zhi‑Yun Chen
Publikováno v:
Molecular Medicine Reports
Our previous study revealed that microRNA (miR) ‑30c represents a potential tumor suppressor gene, the expression of which is associated with decreased oncogenic potential in prostate cancer (PCa) cell lines. However, the functional role and underl
Autor:
Run-Qiang, Yuan
Publikováno v:
Zhonghua nan ke xue = National journal of andrology. 18(12)
Tadalafil, as a selective phosphodiesterase type 5 inhibitor (PDE5I), has revolutionized the treatment of erectile dysfunction (ED) in men. Conventional management of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)
Autor:
Run-qiang, Yuan, Shao-bin, Zheng, Shao-peng, Qiu, Zhi-zhao, Yang, Xin-min, Li, Hua-kuo, Zhou, Ying-jiang, Shi
Publikováno v:
Zhonghua nan ke xue = National journal of andrology. 17(3)
To study the impact of asymptomatic prostatitis on semen parameters.Based on the count of WBC in EPS, we assigned 152 patients with asymptomatic (type IV) prostatitis to Groups A (WBC + to + +) and B (WBC + + + to + + + +), and included 68 normal hea
Autor:
YA‑QIANG HUANG, XIAO‑HUI LING, RUN‑QIANG YUAN, ZHI‑YUN CHEN, SHENG‑BANG YANG, HONG‑XING HUANG, WEI‑DE ZHONG, SHAO‑PENG QIU
Publikováno v:
Molecular Medicine Reports; Sep2017, Vol. 16 Issue 3, p2431-2438, 8p